| Issuer | % of Class | Filed | ||||
|---|---|---|---|---|---|---|
| Schedule 13D · 1 security · may seek to influence control | ||||||
|
Cyclerion Therapeutics, Inc.
13D/A
CYCN · 23255M204
|
19.4% |
7/20/2026
Event 7/16/2026
|
||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.